Selected research
Market Structure
Global Fibrin Sealant (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fibrin Sealant (Human) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fibrin Sealant (Human) include Behringwerke, CSL, Grifols, Immuno, Octapharma, Baxter, Bayer, Hualan Biological and Shanghai RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Fibrin Sealant (Human) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fibrin Sealant (Human) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fibrin Sealant (Human) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fibrin Sealant (Human) market size, projected growth trends, production technologies, key applications, and end-use industries.
Fibrin Sealant (Human) Segment by Company
Behringwerke
CSL
Grifols
Immuno
Octapharma
Baxter
Bayer
Hualan Biological
Shanghai RAAS
Fibrin Sealant (Human) Segment by Type
2mL/Set
4mL/Set
10mL/Set
Fibrin Sealant (Human) Segment by Application
Hospital
Clinic
Other
Fibrin Sealant (Human) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrin Sealant (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrin Sealant (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrin Sealant (Human).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fibrin Sealant (Human) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibrin Sealant (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibrin Sealant (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Fibrin Sealant (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2mL/Set
- 4mL/Set
- 10mL/Set
Applications
- Hospital
- Clinic
- Other
Companies covered
- Behringwerke
- CSL
- Grifols
- Immuno
- Octapharma
- Baxter
- Bayer
- Hualan Biological
- Shanghai RAAS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fibrin Sealant (Human) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fibrin Sealant (Human) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Fibrin Sealant (Human) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Fibrin Sealant (Human) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Fibrin Sealant (Human) Market Dynamics
- 2.1 Fibrin Sealant (Human) Industry Trends
- 2.2 Fibrin Sealant (Human) Industry Drivers
- 2.3 Fibrin Sealant (Human) Industry Opportunities and Challenges
- 2.4 Fibrin Sealant (Human) Industry Restraints
3 Fibrin Sealant (Human) Market by Manufacturers
- 3.1 Global Fibrin Sealant (Human) Revenue by Manufacturers (2021-2026)
- 3.2 Global Fibrin Sealant (Human) Sales by Manufacturers (2021-2026)
- 3.3 Global Fibrin Sealant (Human) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Fibrin Sealant (Human) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fibrin Sealant (Human) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Fibrin Sealant (Human) Manufacturers, Product Type & Application
- 3.7 Global Fibrin Sealant (Human) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fibrin Sealant (Human) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fibrin Sealant (Human) Players Market Share by Revenue in 2025
- 3.8.3 2025 Fibrin Sealant (Human) Tier 1, Tier 2, and Tier 3
4 Fibrin Sealant (Human) Market by Type
- 4.1 Fibrin Sealant (Human) Type Introduction
- 4.1.1 2mL/Set
- 4.1.2 4mL/Set
- 4.1.3 10mL/Set
- 4.2 Global Fibrin Sealant (Human) Sales by Type
- 4.2.1 Global Fibrin Sealant (Human) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fibrin Sealant (Human) Sales by Type (2021-2032)
- 4.2.3 Global Fibrin Sealant (Human) Sales Market Share by Type (2021-2032)
- 4.3 Global Fibrin Sealant (Human) Revenue by Type
- 4.3.1 Global Fibrin Sealant (Human) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 4.3.3 Global Fibrin Sealant (Human) Revenue Market Share by Type (2021-2032)
5 Fibrin Sealant (Human) Market by Application
- 5.1 Fibrin Sealant (Human) Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Fibrin Sealant (Human) Sales by Application
- 5.2.1 Global Fibrin Sealant (Human) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fibrin Sealant (Human) Sales by Application (2021-2032)
- 5.2.3 Global Fibrin Sealant (Human) Sales Market Share by Application (2021-2032)
- 5.3 Global Fibrin Sealant (Human) Revenue by Application
- 5.3.1 Global Fibrin Sealant (Human) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 5.3.3 Global Fibrin Sealant (Human) Revenue Market Share by Application (2021-2032)
6 Global Fibrin Sealant (Human) Sales by Region
- 6.1 Global Fibrin Sealant (Human) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fibrin Sealant (Human) Sales by Region (2021-2032)
- 6.2.1 Global Fibrin Sealant (Human) Sales by Region (2021-2026)
- 6.2.2 Global Fibrin Sealant (Human) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fibrin Sealant (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fibrin Sealant (Human) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fibrin Sealant (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fibrin Sealant (Human) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fibrin Sealant (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fibrin Sealant (Human) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Fibrin Sealant (Human) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Fibrin Sealant (Human) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Fibrin Sealant (Human) Revenue by Region
- 7.1 Global Fibrin Sealant (Human) Revenue by Region
- 7.1.1 Global Fibrin Sealant (Human) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Fibrin Sealant (Human) Revenue by Region (2021-2026)
- 7.1.3 Global Fibrin Sealant (Human) Revenue by Region (2027-2032)
- 7.1.4 Global Fibrin Sealant (Human) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Fibrin Sealant (Human) Revenue (2021-2032)
- 7.2.2 North America Fibrin Sealant (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Fibrin Sealant (Human) Revenue (2021-2032)
- 7.3.2 Europe Fibrin Sealant (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Fibrin Sealant (Human) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Fibrin Sealant (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Fibrin Sealant (Human) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Fibrin Sealant (Human) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Behringwerke
- 8.1.1 Behringwerke Company Information
- 8.1.2 Behringwerke Business Overview
- 8.1.3 Behringwerke Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Behringwerke Fibrin Sealant (Human) Product Portfolio
- 8.1.5 Behringwerke Recent Developments
- 8.2 CSL
- 8.2.1 CSL Company Information
- 8.2.2 CSL Business Overview
- 8.2.3 CSL Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 CSL Fibrin Sealant (Human) Product Portfolio
- 8.2.5 CSL Recent Developments
- 8.3 Grifols
- 8.3.1 Grifols Company Information
- 8.3.2 Grifols Business Overview
- 8.3.3 Grifols Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Grifols Fibrin Sealant (Human) Product Portfolio
- 8.3.5 Grifols Recent Developments
- 8.4 Immuno
- 8.4.1 Immuno Company Information
- 8.4.2 Immuno Business Overview
- 8.4.3 Immuno Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Immuno Fibrin Sealant (Human) Product Portfolio
- 8.4.5 Immuno Recent Developments
- 8.5 Octapharma
- 8.5.1 Octapharma Company Information
- 8.5.2 Octapharma Business Overview
- 8.5.3 Octapharma Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Octapharma Fibrin Sealant (Human) Product Portfolio
- 8.5.5 Octapharma Recent Developments
- 8.6 Baxter
- 8.6.1 Baxter Company Information
- 8.6.2 Baxter Business Overview
- 8.6.3 Baxter Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Baxter Fibrin Sealant (Human) Product Portfolio
- 8.6.5 Baxter Recent Developments
- 8.7 Bayer
- 8.7.1 Bayer Company Information
- 8.7.2 Bayer Business Overview
- 8.7.3 Bayer Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bayer Fibrin Sealant (Human) Product Portfolio
- 8.7.5 Bayer Recent Developments
- 8.8 Hualan Biological
- 8.8.1 Hualan Biological Company Information
- 8.8.2 Hualan Biological Business Overview
- 8.8.3 Hualan Biological Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hualan Biological Fibrin Sealant (Human) Product Portfolio
- 8.8.5 Hualan Biological Recent Developments
- 8.9 Shanghai RAAS
- 8.9.1 Shanghai RAAS Company Information
- 8.9.2 Shanghai RAAS Business Overview
- 8.9.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Shanghai RAAS Fibrin Sealant (Human) Product Portfolio
- 8.9.5 Shanghai RAAS Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fibrin Sealant (Human) Value Chain Analysis
- 9.1.1 Fibrin Sealant (Human) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fibrin Sealant (Human) Production Mode & Process
- 9.2 Fibrin Sealant (Human) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fibrin Sealant (Human) Distributors
- 9.2.3 Fibrin Sealant (Human) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst